Pfizer's Dolsten On Finding Ways To “Accelerate External Science”

Part 2 Of 2

 
• By Jessica Merrill

Worldwide President of R&D Mikael Dolsten talked to Scrip about Pfizer's busy business development track record and the company's ambition to maintain its leadership in breast cancer.

big fish eating small fish
Pfizer has been an active dealmaker this year • Source: Shutterstock

More from Deals

More from Business